Have the results of LAP07 caused your institution to pursue more aggressive systemic therapy before radiotherapy in the treatment of pancreatic cancer?
Is better systemic control needed to make radiation therapy beneficial?
Answer from: Radiation Oncologist at Academic Institution
Chemotherapy is the standard of care for locally advanced pancreatic cancer. There are two standard regimens, Gem/A and FolfirinOX. These regimens are modestly better then gemcitabine alone, but there is a clear barrier in median survival of 12 months. This will probably never be surpassed with chem...